664
Views
4
CrossRef citations to date
0
Altmetric
Clinical

Measuring quality of life in ALS/MND: validation of the WHOQOL-BREF

ORCID Icon, , , , , , , ORCID Icon, ORCID Icon, , , , ORCID Icon, , ORCID Icon, & show all
Pages 364-372 | Received 05 Jun 2019, Accepted 30 Mar 2020, Published online: 27 Jun 2020

References

  • Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995;273:59–65.
  • Mayo NE, Moriello C, Asano M, van der Spuy S, Finch L. The extent to which common health-related quality of life indices capture constructs beyond symptoms and function. Qual Life Res. 2011;20:621–7.
  • Simmons Z. Patient-perceived outcomes and quality of life in ALS. Neurotherapeutics 2015;12:394–402.
  • Robbins RA, Simmons Z, Bremer BA, Walsh SM, Fischer S. Quality of life in ALS is maintained as physical function declines. Neurology 2001;56:442–4.
  • Neudert C, Wasner M, Borasio GD. Individual quality of life is not correlated with health-related quality of life or physical function in patients with amyotrophic lateral sclerosis. J Palliat Med. 2004;7:551–7.
  • Group TW. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995;41:1403–9.
  • Skevington SM, Lotfy M, O'Connell KA. The World Health Organization’s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004;13:299–310.
  • The WHOQOL G. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998;46:1569–85.
  • Schlüter DK, Tennant A, Mills R, Diggle PJ, Young CA. Risk factors for social withdrawal in amyotrophic lateral sclerosis/motor neurone disease. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:591–8.
  • Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
  • Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
  • Gibbons CJ, Mills RJ, Thornton EW, Ealing J, Mitchell JD, Shaw PJ, et al. Rasch analysis of the hospital anxiety and depression scale (HADS) for use in motor neurone disease. Health Qual Life Outcomes. 2011;9:82–90.
  • Rehm J, Üstün TB, Saxena S, Nelson CB, Chatterji S, Ivis F, et al. On the development and psychometric testing of the WHO screening instrument to assess disablement in the general population. Int J Method Psychiat Res. 1999;8:110–22.
  • Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L. ).Qual Life Res. 2011;20:1727–36.
  • Rasch G. Probabilistic models for some intelligence and attainment tests. Chicago: University of Chicago Press; 1960.
  • da Rocha NS, Chachamovich E, de Almeida Fleck MP, Tennant A. An introduction to Rasch analysis for psychiatric practice and research. J Psychiatr Res. 2013;47:141–8.
  • Gustafsson J. Testing and obtaining fit of data to the Rasch model. Brit J Math Stat Psy. 1980;33:205–33.
  • Christensen KB, Makransky G, Horton M. Critical values for Yen’s Q3: identification of local dependence in the Rasch model using residual correlations. Appl Psychol Meas. 2017;41:178–94.
  • Wainer H, Kiely G. Item clusters and computer adaptive testing: a case for testlets. J Educ Meas. 1987;24:185–202.
  • Andrich D. Components of variance of scales with a bifactor subscale structure from two calculations of alpha. Educ Meas. 2016;35:25–30.
  • Rodriguez A, Reise S, Haviland M. Evaluating bi-factor models: calculating and interpreting statistical indices. Psychol Methods. 2016;21:137–50.
  • Teresi JA, Kleinman M, Ocepek-Welikson K. Modern psychometric methods for detection of differential item functioning: application to cognitive assessment measures. Statist Med. 2000;19:1651–83.
  • Stauffer ME, Taylor SD, Watson DJ, Peloso PM, Morrison A. Definition of nonresponse to analgesic treatment of arthritic pain: an analytical literature review of the smallest detectable difference, the minimal detectable change, and the minimal clinically important difference on the pain visual analog scale. Int J Inflammation. 2011;2011:1–6.
  • Noerholm V, Groenvold M, Watt T, Bjorner JB, Rasmussen NA, Bech P. Quality of life in the Danish general population–normative data and validity of WHOQOL-BREF using Rasch and item response theory models. Qual Life Res. 2004;13:531–40.
  • Perera HN, Izadikhah Z, O’Connor P, McIlveen P. Resolving dimensionality problems with WHOQOL-BREF item responses. Assessment 2018;25:1014–25.
  • Felgoise SH, Feinberg R, Stephens HE, Barkhaus P, Boylan K, Caress J, et al. Amyotrophic lateral sclerosis-specific quality of life-short form (ALSSQOL-SF): a brief, reliable, and valid version of the ALSSQOL-R. Muscle Nerve. 2018;58:646–54.
  • Skevington SM, McCrate FM. Expecting a good quality of life in health: assessing people with diverse diseases and conditions using the WHOQOL-BREF. Health Expect. 2012;15:49–62.
  • de Mol M, Visser S, Aerts J, Lodder P, de Vries J, den Oudsten BL. Satisfactory results of a psychometric analysis and calculation of minimal clinically important differences of the World Health Organization quality of life-BREF questionnaire in an observational cohort study with lung cancer and mesothelioma patients. BMC Cancer. 2018;18:1173.
  • Franchignoni F, Mora G, Giordano A, Volanti P, Chio A. Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis. J Neurol Neurosurg Psychiatry. 2013;84:1340–5.
  • Bacci ED, Staniewska D, Coyne KS, Boyer S, White LA, Zach N, et al. Item response theory analysis of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised in the Pooled Resource Open-Access ALS Clinical Trials Database. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:157–67.
  • Bakker LA, Schroder CD, van Es MA, Westers P, Visser-Meily JMA, van den Berg LH. Assessment of the factorial validity and reliability of the ALSFRS-R: a revision of its measurement model. J Neurol. 2017;264:1413–20.
  • Young C, Paris-Davies J, Mills R, Tennant A, editors. Can you validly use a total ALSFRS-R score? A Rasch analysis to provide interval scale estimates. 29th International Symposium on ALS/MND, Glasgow: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2018.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.